S
SinoMab BioScience Ltd
HKEX:3681
SinoMab BioScience Ltd
HKEX:3681
Price:
1.54
HKD
1.99%
Market Cap:
HK$2.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
SinoMab BioScience Ltd
HKEX:3681
|
HK |
|
Czr Resources Ltd
ASX:CZR
|
AU |
|
Z
|
Zinzino AB
STO:ZZ B
|
SE |
Balance Sheet
Balance Sheet Decomposition
SinoMab BioScience Ltd
SinoMab BioScience Ltd
Balance Sheet Decomposition is not available for
SinoMab BioScience Ltd
SinoMab BioScience Ltd
Balance Sheet
SinoMab BioScience Ltd
SinoMab BioScience Ltd
Currency: CNY
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
66
|
42
|
1 201
|
810
|
563
|
346
|
204
|
62
|
323
|
|
| Cash Equivalents |
66
|
42
|
1 201
|
810
|
563
|
346
|
204
|
62
|
323
|
|
| Short-Term Investments |
47
|
0
|
0
|
93
|
0
|
30
|
31
|
45
|
49
|
|
| Total Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
14
|
8
|
14
|
31
|
33
|
71
|
36
|
78
|
18
|
|
| Total Current Assets |
127
|
50
|
1 215
|
934
|
596
|
447
|
270
|
185
|
390
|
|
| PP&E Net |
35
|
38
|
42
|
146
|
356
|
486
|
575
|
566
|
501
|
|
| PP&E Gross |
35
|
38
|
42
|
146
|
356
|
486
|
575
|
566
|
0
|
|
| Accumulated Depreciation |
5
|
7
|
8
|
12
|
21
|
36
|
50
|
65
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
2
|
3
|
2
|
1
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
32
|
27
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
27
|
17
|
61
|
73
|
1
|
1
|
17
|
|
| Total Assets |
162
N/A
|
89
-45%
|
1 284
+1 346%
|
1 130
-12%
|
1 042
-8%
|
1 008
-3%
|
848
-16%
|
753
-11%
|
908
+21%
|
|
| Liabilities | ||||||||||
| Accrued Liabilities |
1
|
1
|
57
|
9
|
7
|
11
|
5
|
3
|
0
|
|
| Short-Term Debt |
170
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
14
|
17
|
8
|
14
|
12
|
46
|
71
|
126
|
142
|
|
| Other Current Liabilities |
0
|
0
|
41
|
36
|
79
|
131
|
96
|
75
|
62
|
|
| Total Current Liabilities |
185
|
28
|
107
|
59
|
98
|
187
|
173
|
203
|
204
|
|
| Long-Term Debt |
28
|
33
|
46
|
84
|
263
|
311
|
380
|
357
|
196
|
|
| Total Liabilities |
213
N/A
|
61
-71%
|
152
+148%
|
143
-6%
|
361
+154%
|
499
+38%
|
552
+11%
|
560
+1%
|
400
-29%
|
|
| Equity | ||||||||||
| Common Stock |
153
|
302
|
1 679
|
1 679
|
1 679
|
1 725
|
1 725
|
1 790
|
2 218
|
|
| Retained Earnings |
192
|
267
|
544
|
631
|
857
|
1 140
|
1 367
|
1 546
|
1 710
|
|
| Other Equity |
11
|
7
|
4
|
61
|
142
|
76
|
62
|
52
|
0
|
|
| Total Equity |
51
N/A
|
27
N/A
|
1 132
+4 030%
|
987
-13%
|
680
-31%
|
510
-25%
|
296
-42%
|
193
-35%
|
508
+163%
|
|
| Total Liabilities & Equity |
162
N/A
|
89
-45%
|
1 284
+1 346%
|
1 130
-12%
|
1 042
-8%
|
1 008
-3%
|
848
-16%
|
753
-11%
|
908
+21%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
824
|
824
|
1 006
|
1 006
|
1 006
|
1 035
|
1 035
|
1 092
|
1 387
|
|
Switch to:
Switch to:
See Also
Discover More
